Dr John Moller
Chief Operating Officer - Asia, Novotech CRO, NSW, Australia
Dr John Moller joined Novotech in January 2014 to lead the expansion of Novotech’s Asia operations, and became CEO in 2017. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of the parent company Virtus Health. John was previously a management consultant with the Boston Consulting Group specialising in developing growth and operational improvement initiatives with a particular focus on healthcare. John has a Medical Degree from the University of Auckland, a degree in advanced logic from the University of Canterbury and an MBA from the University of Oxford.
Trends in the Industry (Sponsor/CRO)
The rate of change in the global biopharmaceutical industry continues to accelerate and creates both risks and opportunities for participants in the clinical trial sector. While the outcome and timing of macro changes is always difficult to predict, it is critical that industry participants in New Zealand and the region understand and can quickly react to emerging trends.
This presentation will draw Novotech’s experience as the largest biotech specialist CRO in the region, managing several hundred trials for US, European and Asian sponsors.
Important topics addressed will include: